Pacific Biosciences of California, Inc.

US$2.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PACBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (12.40%)
Div yield —
ROE —
Medical Devices
Beta (5Y) 2.20
PE TTM —
TSR TTM (3.63%)
Mkt cap US$705.6M
ROIC (48.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.42
7.17%
257.69%
Hold 1|4|10|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
2.93%
(2.74%)
(6.60%)
(0.84%)
Revenue$M
58.07
57.11
56.92
57.19
6.51%
2.19%
(3.56%)
(3.95%)
Peers (US$705.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.318
0.095
0.084
EBIT/Intx
0.767
0.301
0.293
Own earn%
179.19
(12.11)
(8.51)
Sh yield%
25.14
39.54
39.46
Owners
Insiders/Inst%
12.33
83.14
Short interest%
1.84
SBC / revenue%
4.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
1